Cafepharma Today

June 27 2025 - ACIP skips votes on COVID and Moderna’s mRESVIA but scrutinzes mRNA vaccine safety
ACIP skips votes on COVID and Moderna’s mRESVIA but scrutinzes mRNA vaccine safety
VC legal dispute threatens biotech startups
Multiple sclerosis market expected to reach $25.9bn across the 7MM by 2034
Novo Nordisk Foundation gives $75m for R&D 'challenges'
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The top 10 patent losses of 2015
Fierce Pharma
Friday, December 19, 2014 - 8:35am
tags:
patents, Lantus, Abilify, Copaxone, Neulasta, Tracleer, Namenda, Avodart, Jalyn, Zyvox, Androgel, Synagis, Sanofi, Bristol-Myers Squibb, Otsuka, Teva Pharmaceutical, Amgen, Actelion, Actavis, GSK, Pfizer, AbbVie, AstraZeneca
Double blow for Roche as breast cancer, Alzheimer's studies fail
Yahoo/Reuters
Friday, December 19, 2014 - 8:29am
tags:
Roche, Alzheimer's disease, breast cancer, Kadcyla, gantenerumab
Record Pharma-Deal Year Not Enough to Sell Mature Drugs
Bloomberg
Friday, December 19, 2014 - 8:22am
tags:
Sanofi, GSK, UCB Pharmaceuticals
GSK Ebola vaccine trial seen moving to wider phase in February
Yahoo/Reuters
Friday, December 19, 2014 - 8:21am
tags:
GSK, ebola virus, vaccines
Eli Lilly agrees to development deal for fast-acting insulin with French drugmaker Adocia
Yahoo/AP
Friday, December 19, 2014 - 8:19am
tags:
Eli Lilly, insulin, R&D, diabetes, Adocia
Merck Begins Tender Offer to Acquire Cubist
Yahoo
Friday, December 19, 2014 - 8:18am
tags:
Merck, Cubist, M&A
Pets and Vets: Pharma Animal Health Units are Subject to Less Scrutiny
WSJ Pharmalot
Thursday, December 18, 2014 - 6:36pm
tags:
animal health
FDA clears Lannett's generic eye drug
Seeking Alpha
Thursday, December 18, 2014 - 6:35pm
tags:
FDA, Lannett, generics
Blowout Year for IPOs to End with Big Biotech Offering
WSJ Online
Thursday, December 18, 2014 - 6:30pm
tags:
IPOs, biotech, Bluebird Bio, Juno Therapeutics, Kite Pharma
Pfizer bets on Duchenne MD treatment
Medical Marketing and Media
Thursday, December 18, 2014 - 4:30pm
tags:
Pfizer, Duchenne Muscular Dystrophy, Translarna
Roche to pay up to $489 mln for next-generation antibody developer
Reuters
Thursday, December 18, 2014 - 4:12pm
tags:
Roche, M&A, R&D, Dutalys, antibodies
The FDA May Find Some Use For Rapivab And Approve The Influenza Antiviral
Seeking Alpha
Thursday, December 18, 2014 - 4:09pm
tags:
FDA, Rapivab, Biocryst, Flu, antivirals
GlaxoSmithKline CEO: Chin up, investors. Dividend's safe, and Novartis deal awaits
Fierce Pharma
Thursday, December 18, 2014 - 4:06pm
tags:
GSK, Pharma CEOs, Novartis, dividends, Andrew Witty
AbbVie: Here’s How It Could Differentiate Itself From Gilead
Barron's
Thursday, December 18, 2014 - 4:04pm
tags:
AbbVie, Gilead Sciences, hepatitis C, drug pricing
The Winners for Best and Worst Biotech CEOs of 2014 Are...
TheStreet.com
Thursday, December 18, 2014 - 11:25am
tags:
biotech, Bluebird Bio, Agios Pharmaceuticals
Bellicum pulls off a $140M IPO as CAR-T has its day on Wall Street
Fierce Biotech
Thursday, December 18, 2014 - 10:26am
tags:
Bellicum, IPOs, CAR-T
Lundbeck pulls the plug on its fast-tracked stroke drug
Fierce Biotech
Thursday, December 18, 2014 - 10:25am
tags:
Lundbeck, stroke, desmoteplase
Positive Phase 3 results for new formulation of Pfizer pain med
Seeking Alpha
Thursday, December 18, 2014 - 10:15am
tags:
Pfizer, Lyrica, postherpetic neuralgia
Pharma Stocks To Keep An Eye On: Pozen Inc. (POZN), Paratek Pharmaceuticals (PRTK), Oncothyreon Inc. (ONTY), Tetraphase Pharmaceuticals (TTPH)
Bidness Etc.
Thursday, December 18, 2014 - 10:07am
tags:
Pozen, Tetraphase Pharmaceuticals, Paratek, Oncothyreon
Merck beefs up its cancer drug pipeline in $375M OncoEthix buyout
Fierce Biotech
Thursday, December 18, 2014 - 10:04am
tags:
Merck, OncoEthix, M&A, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The "Healthy Vaccinee" Effect
In the Pipeline
The Continuing Crisis, Part XVI: Get the Hell Out of Your Building
In the Pipeline
Tiny Crystals from Small Extracts
In the Pipeline
Hexanitrogen
In the Pipeline
Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.